NEW DELHI: The has contradicted a New York Times report reprinted in TOI on February 16 — 'India-made drugs trigger safety concerns in US'. The... ...http://timesofindia.indiatimes.com/business/india-business/Allegations-of-fake-India-made-medicines-baseless-DCGI/articleshow/31701885.cms
press trust of india NEW DELHI, 8 MARCH: Taking up the case of domestic pharma sector with the USA, India has pitched for review of America's... ...http://www.thestatesman.net/news/43316-india-for-review-of-us-pharma-policy.html
Drug maker Ranbaxy Laboratories, which is reeling under regulatory action from the US Food and Drug Administration (USFDA), has recalled more than... ...http://www.thehindu.com/business/ranbaxy-recalls-two-lots-of-generic-lipitor-in-the-us/article5764594.ece
Drug major Ranbaxy Laboratories has recalled over 64,000 bottles of Atorvastatin calcium tablets, a generic version of cholesterol-lowering drug... ...http://www.thehindubusinessline.com/companies/ranbaxy-recalls-over-64000-bottles-of-generic-lipitor-in-us/article5764351.ece
Mumbai : Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than... ...http://profit.ndtv.com/news/corporates/article-ranbaxy-recalls-some-batches-of-generic-lipitor-in-latest-quality-blow-382453?pfrom=home-latest
Miocon is pleased to introduce...